Please enter a name for your new saved list

Create
Cancel

Nobivac Feline 1-HCPCh + FeLV Vaccine

Nobivac Feline 1-HCPCh + FeLV Vaccine

Supplied By: Merck (065267)


SKU
006489


Unit of
Measure
25 x 1 Dose


Pack
Type
Box


Case
Qty
10

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jun- 2020 May- 2020 Apr- 2020 Mar- 2020 Feb- 2020 Jan- 2020 Dec- 2019 Nov- 2019 Oct- 2019 Sep- 2019 Aug- 2019 Jul- 2019 Jun- 2019
{{purchaseHistoryItem}}


SKU
006489


Size
25 x 1 Dose

Case
Qty
10

Purchase History

Jun- 2020 {{productPurchaseHistory['006489'][0]}} Nov- 2019 {{productPurchaseHistory['006489'][0+7]}}
May- 2020 {{productPurchaseHistory['006489'][1]}} Oct- 2019 {{productPurchaseHistory['006489'][1+7]}}
Apr- 2020 {{productPurchaseHistory['006489'][2]}} Sep- 2019 {{productPurchaseHistory['006489'][2+7]}}
Mar- 2020 {{productPurchaseHistory['006489'][3]}} Aug- 2019 {{productPurchaseHistory['006489'][3+7]}}
Feb- 2020 {{productPurchaseHistory['006489'][4]}} Jul- 2019 {{productPurchaseHistory['006489'][4+7]}}
Jan- 2020 {{productPurchaseHistory['006489'][5]}} Jun- 2019 {{productPurchaseHistory['006489'][5+7]}}
Dec- 2019 {{productPurchaseHistory['006489'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}
{{compareProd.desc}}

{{compareMessage}}

Product Description

The only combination vaccine that provides 2-year duration of immunity for feline leukemia virus (FeLV) and 1-year protection against feline rhinotracheitis, calicivirus, panleukopenia, and Chlamydophila.

Features & Benefits

  • A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), feline calicivirus (FCV), and feline Chlamydophila in addition to providing extensive 2-year immunity coverage for feline leukemia
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats
  • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia
  • The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination
  • 96% of vaccinated cats were protected against persistent viremia after FeLV challenge
  • In a 2-year study involving 23 FeLV-negative cats:
  • After 12 weeks, 83% of vaccinates were free of persistent and transient viremia
  • All 11 control cats (100%) developed persistent viremia
  • Results showed that cats developed immunity solely through the initial vaccination series
  • Optimal choice for outdoor cats and cats that are boarded frequently

Related Products

 

SIMPLIFY YOUR MAILBOX AND GO GREEN

Have you signed up for eStatements yet? They're a great way to receive less paper mail and keep your statements organized in your email inbox!

Learn More

Careers

Are you looking for a place to let your talents shine? At Covetrus, we help our practitioner customers better serve their patients and take pride in providing the best customer experience possible. Search our open positions to see our available opportunities.

Learn More

Newsletter

Stay current with what’s going on with Covetrus, subscribe to receive our newsletter and email communications. Subscribers will receive the latest information in practice management, sales and marketing, animal health, and more.

Sign Up